Activity of Research-Grade Pemivibart against Recent SARS-CoV-2 JN.1 Sublineages

被引：2
|
作者：
Wang, Qian [1 ]
Guo, Yicheng [1 ]
Ho, Jerren [1 ]
Ho, David D. [1 ]
机构：
[1] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY 10027 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2024年 / 391卷 / 19期
关键词：
D O I：
10.1056/NEJMc2410203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1863 / 1864
页数：2
相关论文
共 50 条
  • [21] SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences
    Wang, Xinling
    Lu, Lu
    Jiang, Shibo
    TRENDS IN IMMUNOLOGY, 2024, 45 (02) : 81 - 84
  • [22] Proteic and mRNA XBB.1.5 SARS-CoV-2 vaccines elicit a close neutralising response against JN.1 in PWH
    Vergori, Alessandra
    Matusali, Giulia
    Cimini, Eleonora
    Cozzi-Lepri, Alessandro
    Cecilia, Federico
    Mariotti, Davide
    Colavita, Francesca
    Gili, Simona
    Cristofanelli, Flavia
    Fusto, Marisa
    Mazzotta, Valentina
    Paulicelli, Jessica
    Gagliardini, Roberta
    Girardi, Enrico
    Maggi, Fabrizio
    Antinori, Andrea
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 304 - 305
  • [23] Effectiveness of BNT162b2 XBB Vaccine Against XBB and JN.1 Sublineages
    Tartof, Sara Y.
    Slezak, Jeff M.
    Puzniak, Laura
    Frankland, Timothy B.
    Ackerson, Bradley K.
    Jodar, Luis
    Mclaughlin, John M.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (07):
  • [24] Evolving immune evasion and transmissibility of SARS-CoV-2: The emergence of JN.1 variant and its global impact
    Ou, Guanyong
    Yang, Yang
    Zhang, Shengjie
    Niu, Shiyu
    Cai, Qingxian
    Liu, Yingxia
    Lu, Hongzhou
    DRUG DISCOVERIES AND THERAPEUTICS, 2024, 18 (01): : 67 - 70
  • [25] Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC
    Arora, Prerna
    Happle, Christine
    Kempf, Amy
    Nehlmeier, Inga
    Stankov, Metodi, V
    Dopfer-Jablonka, Alexandra
    Behrens, Georg M. N.
    Poehlmann, Stefan
    Hoffmann, Markus
    LANCET INFECTIOUS DISEASES, 2024, 24 (12): : e731 - e732
  • [26] Immune escape and attenuated severity associated with the SARS-CoV-2 BA.2.86/JN.1 lineage
    Lewnard, Joseph A.
    Mahale, Parag
    Malden, Debbie
    Hong, Vennis
    Ackerson, Bradley K.
    Lewin, Bruno J.
    Link-Gelles, Ruth
    Feldstein, Leora R.
    Lipsitch, Marc
    Tartof, Sara Y.
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [27] Structural basis for the evolution and antibody evasion of SARS-CoV-2 BA.2.86 and JN.1 subvariants
    Yang, Haonan
    Guo, Huimin
    Wang, Aojie
    Cao, Liwei
    Fan, Qing
    Jiang, Jie
    Wang, Miao
    Lin, Lin
    Ge, Xiangyang
    Wang, Haiyan
    Zhang, Runze
    Liao, Ming
    Yan, Renhong
    Ju, Bin
    Zhang, Zheng
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [28] Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure
    Yang, Sijie
    Yu, Yuanling
    Xu, Yanli
    Jian, Fanchong
    Song, Weiliang
    Yisimayi, Ayijiang
    Wang, Peng
    Wang, Jing
    Liu, Jingyi
    Yu, Lingling
    Niu, Xiao
    Wang, Yao
    Shao, Fei
    Jin, Ronghua
    Cao, Youchun
    LANCET INFECTIOUS DISEASES, 2024, 24 (02): : e70 - e72
  • [29] Appearance and Prevalence of JN.1 SARS-CoV-2 Variant in India and Its Clinical Profile in the State of Maharashtra
    Karyakarte, Rajesh P.
    Das, Rashmita
    Rajmane, Mansi, V
    Dudhate, Sonali
    Agarasen, Jeanne
    Pillai, Praveena
    Chandankhede, Priyanka M.
    Labhshetwar, Rutika S.
    Gadiyal, Yogita
    Kulkarni, Preeti P.
    Nizarudeen, Safanah
    Yanamandra, Sushma
    Taji, Nyabom
    Joshi, Suvarna
    Potdar, Varsha
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [30] T Cell Responses to BA.2.86 and JN.1 SARS-CoV-2 Variants in Elderly Subjects
    Segato, Irene
    Mele, Dalila
    Forlani, Greta
    Dalla Gasperina, Daniela
    Mondelli, Mario U.
    Varchetta, Stefania
    VACCINES, 2024, 12 (12)
12345